TXNRD1 and ovarian carcinoma: A Kaplan Meir survival curve was generated on a sample of over one-thousand ovarian cancer patients, which were grouped separately based on high and low TrxR1 expression; results showed that there was a significant difference in the overall survival of patients in the high TrxR1 expression group in comparison to the low TrxR1 expression group; a hazard ratio of 1.5 indicated that patients with a high TrxR1 expression have 1.5 times chances of reaching a fifty percent overall survival in a shorter time than patients in the low TrxR1 expression group [40].